Related Experiment Video

Updated: Jun 5, 2026

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

Infant myocardial recovery with device and surgical repair

Jack Copeland1, Hannah Zimmerman

  • 1Department of Surgery, University of California San Diego, San Diego, California 92103, USA. jackcope3@gmail.com

The Annals of Thoracic Surgery
|December 22, 2010
PubMed

Insights

A novel approach using a left ventricular assist device and septal aneurysmectomy successfully treated severe infant heart failure. This intervention led to significant recovery of heart function and successful patient discharge.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Infantile heart failure presents significant management challenges.
  • Severe left ventricular dysfunction requires advanced therapeutic strategies.

Observation:

  • A 4-month-old infant with severe heart failure (ejection fraction 10%) deteriorated despite maximal medical and ventilatory support.
  • Persistent septal dyskinesis complicated weaning from mechanical ventilation.

Findings:

  • Implantation of a centrifugal left ventricular assist device (LVAD) facilitated reverse remodeling and allowed device weaning after 9 days.
  • Subsequent ventricular septal aneurysmectomy resolved septal dyskinesis, enabling successful extubation and discharge.
  • The patient demonstrated remarkable recovery, with ejection fraction improving to 65%.

Implications:

  • This case highlights the potential of mechanical circulatory support and surgical intervention in managing complex pediatric heart failure.
  • Early intervention with LVAD and septal repair can lead to favorable long-term outcomes in infants.
  • This approach offers a viable treatment option for neonates and infants with life-threatening cardiac conditions.

More Related Videos

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model07:03

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Published on: March 18, 2019

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging08:14

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging

Published on: March 17, 2020

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...